These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 2507574

  • 1. Rapid inhibitory effects of an LHRH agonist implant on the oestrogen-induced LH surge and the induction of a defective luteal phase after an agonist-induced ovulation in the macaque.
    Fraser HM, Lunn SF.
    Hum Reprod; 1989 Jul; 4(5):506-12. PubMed ID: 2507574
    [Abstract] [Full Text] [Related]

  • 2. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
    Grimes EM, Thompson IE, Taymor ML.
    Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349
    [Abstract] [Full Text] [Related]

  • 3. Effect of LHRH immunoneutralization on follicular development, the LH surge and luteal function in the stumptailed macaque monkey (Macaca arctoides).
    Fraser HM, McNeilly AS, Abbott M, Steiner RA.
    J Reprod Fertil; 1986 Jan; 76(1):299-309. PubMed ID: 3511254
    [Abstract] [Full Text] [Related]

  • 4. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM, Nestor JJ, Vickery BH.
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [Abstract] [Full Text] [Related]

  • 5. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
    Lemarchand-Béraud T, Reymond M, Rappoport G, Magrini G, Gomez J.
    Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
    [Abstract] [Full Text] [Related]

  • 6. Contraception with an LHRH agonist: effect on gonadotrophin and steroid secretion patterns.
    Kuhl H, Jung C, Taubert HD.
    Clin Endocrinol (Oxf); 1984 Aug; 21(2):179-88. PubMed ID: 6432376
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effects of treatment with an LHRH antagonist on the ovulatory cycle are reduced when administered during the late follicular phase.
    Fraser HM.
    Contraception; 1990 Jan; 41(1):73-83. PubMed ID: 2105873
    [Abstract] [Full Text] [Related]

  • 8. Influence of the gonad on the degree of suppression induced by an LHRH agonist implant in the marmoset monkey.
    Lunn SF, Cowen GM, Morris KD, Fraser HM.
    J Endocrinol; 1992 Feb; 132(2):217-24. PubMed ID: 1541921
    [Abstract] [Full Text] [Related]

  • 9. Initiation of high dose gonadotrophin-releasing hormone antagonist treatment during the late follicular phase in the macaque abolishes luteal function irrespective of effects upon the luteinizing hormone surge.
    Fraser HM, Lunn SF, Morris KD, Deghenghi R.
    Hum Reprod; 1997 Mar; 12(3):430-5. PubMed ID: 9130734
    [Abstract] [Full Text] [Related]

  • 10. Effect of oestrogen on gonadotrophin release in stumptailed monkeys (Macaca arctoides) treated chronically with an agonist analogue of luteinizing hormone releasing hormone.
    Fraser HM.
    J Endocrinol; 1981 Dec; 91(3):525-30. PubMed ID: 6799604
    [Abstract] [Full Text] [Related]

  • 11. Activity of gonadotrophin surge-attenuating factor during the luteal phase in superovulated women.
    Messinis IE, MacTavish A, Templeton AA.
    J Reprod Fertil; 1993 Jan; 97(1):271-5. PubMed ID: 8464020
    [Abstract] [Full Text] [Related]

  • 12. Inhibitory effects of a luteinizing-hormone-releasing hormone agonist implant on ovine fetal gonadotrophin secretion and pituitary sensitivity to luteinizing-hormone-releasing hormone.
    Brooks AN, McNeilly AS.
    J Reprod Fertil; 1992 Nov; 96(2):785-92. PubMed ID: 1339858
    [Abstract] [Full Text] [Related]

  • 13. Suppression of follicular maturation by infusion of a luteinizing hormone-releasing hormone agonist starting during the late luteal phase in the stumptailed macaque monkey.
    Fraser HM, Sandow J.
    J Clin Endocrinol Metab; 1985 Mar; 60(3):579-84. PubMed ID: 3919049
    [Abstract] [Full Text] [Related]

  • 14. Blockade of LH and FSH secretion by LH-releasing hormone, by the LH-releasing hormone analogue, buserelin, and by combined treatment with LH-releasing hormone and oestradiol benzoate.
    Schuiling GA, Pols-Valkhof N, van der Schaaf-Verdonk GC, Koiter TR.
    J Endocrinol; 1984 Dec; 103(3):301-9. PubMed ID: 6438265
    [Abstract] [Full Text] [Related]

  • 15. Effects of an LH-releasing hormone antagonist on the secretion of LH, FSH, prolactin and ovarian steroids at different stages of the luteal phase in the stumptailed macaque (Macaca arctoides).
    Fraser HM, Abbott M, Laird NC, McNeilly AS, Nestor JJ, Vickery BH.
    J Endocrinol; 1986 Oct; 111(1):83-90. PubMed ID: 3097236
    [Abstract] [Full Text] [Related]

  • 16. Ovarian steroid modulation of gonadotropin secretion and pituitary responsiveness to luteinizing hormone-releasing hormone in the female hamster.
    Shander D, Goldman B.
    Endocrinology; 1978 Oct; 103(4):1383-93. PubMed ID: 369849
    [Abstract] [Full Text] [Related]

  • 17. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
    Molskness TA, Woodruff TK, Hess DL, Dahl KD, Stouffer RL.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
    [Abstract] [Full Text] [Related]

  • 18. Lack of suppressive action of luteal factors from sheep corpus luteum on LH response to exogenous LHRH in ovariectomized, pregnant and post-partum ewes.
    Al-Gubory KH.
    Eur J Endocrinol; 1997 Jan; 136(1):114-20. PubMed ID: 9037137
    [Abstract] [Full Text] [Related]

  • 19. Hypersensitivity of the human gonadotrophs to the repeated administration of small doses of LH-RH.
    Faure N, Olivier GC.
    Horm Res; 1978 Jan; 9(1):12-21. PubMed ID: 338460
    [Abstract] [Full Text] [Related]

  • 20. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaum RE, Diedrich K, Bustion S, Loumaye E, Fauser BC.
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.